Going Nuclear 2: The Role of XPO1 in Diffuse Large B-cell Lymphoma

Join lymphoma experts Dr. Peter Martin, Dr. Erlene Seymour, and Dr. Tom Witzig for a discussion of recent advances in patient care. You will learn how inhibiting a key protein, XPO1, is impacting the current treatment paradigm.

Friday, January 22, 2021
1-2 PM (EST)